More Than $10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying - CVS Health (NYSE:CVS), Kymera Therapeutics (NASDAQ:KYMR)

Although U.S. stocks closed slightly higher on Monday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Kymera Therapeutics

The Trade: Kymera Therapeutics, Inc. (NASDAQ:KYMR) Director Mark Lampert acquired a total of 414,105 shares an average price of $12.80. To acquire these shares, it cost around $5.3 million.
What’s Happening: Kymera Therapeutics posted downbeat third-quarter results.
What Kymera Therapeutics Does: Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases.

STAAR Surgical

The Trade: STAAR Surgical Company (NASDAQ:STAA) 10% owner Neal Bradsher acquired a total of 309,154 shares at an average price of $34.93. To acquire these shares, it cost around $10.8 million.
What’s Happening: Staar Surgical reported better-than-expected earnings for its third quarter.
What STAAR Surgical Does: Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye.

Don’t forget to check out our premarket coverage here

CVS Health

The Trade: CVS Health Corporation (NYSE:CVS) Director Edward J Ludwig bought a total of 2,000 shares at an average price of $70.47. To acquire these shares, it cost around $140,930.
What’s Happening: CVS Health reported better-than-expected third-quarter earnings.
What CVS Health Does: CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the U.S.

V.F. Corporation

The Trade: V.F. Corporation (NYSE:VFC) Director Matthew J Shattock bought a total of 20,000 shares at an average price of $15.31. The insider spent around $306,140 to buy those shares.
What’s Happening: VF Corporation recently reported mixed second-quarter financial results and issued guidance.
What V.F. Corporation Does: VF designs, produces, and distributes branded apparel, footwear, and accessories. Its apparel categories are active, outdoor, and work.

Check This Out: Uber, D.R. Horton And 3 Stocks To Watch Heading Into Tuesday

CVSCVS Health Corp

$76.250.16%

Overview

KYMRKymera Therapeutics Inc

$79.03-%

STAAStaar Surgical Co

$18.84-%

VFCVF Corp

$15.96-%

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.